Daily Sepsis Research Analysis
Three high-impact sepsis studies advance bedside risk stratification and screening. A large pediatric ED cohort shows qPS4 screens Phoenix sepsis and septic shock more sensitively than LqSOFA and a common 2-stage tool. Two adult ICU cohorts identify dynamic, actionable physiologic biomarkers—low pulse pressure patterns and stress hyperglycemia ratio (especially SHRmax)—that robustly predict mortality.
Summary
Three high-impact sepsis studies advance bedside risk stratification and screening. A large pediatric ED cohort shows qPS4 screens Phoenix sepsis and septic shock more sensitively than LqSOFA and a common 2-stage tool. Two adult ICU cohorts identify dynamic, actionable physiologic biomarkers—low pulse pressure patterns and stress hyperglycemia ratio (especially SHRmax)—that robustly predict mortality.
Research Themes
- Pediatric sepsis screening validation
- Dynamic hemodynamic phenotyping in ICU sepsis
- Metabolic stress biomarkers for prognostication
Selected Articles
1. Comparing Screening Tools for Predicting Phoenix Criteria Sepsis and Septic Shock Among Children.
In a 47,176-encounter pediatric ED cohort, qPS4 identified Phoenix-defined sepsis and septic shock with substantially higher sensitivity than LqSOFA and a widely used CHOP 2-stage screen while maintaining similar specificity. These findings support qPS4 as a more effective bedside screening tool for early pediatric sepsis/shock recognition.
Impact: Head-to-head performance against established tools in a very large cohort directly informs pediatric ED screening practice under the Phoenix framework.
Clinical Implications: Hospitals adopting Phoenix criteria can prioritize qPS4 to improve early detection of sepsis and septic shock in children, potentially accelerating antibiotics and hemodynamic support.
Key Findings
- qPS4 sensitivity for Phoenix sepsis: 67.8% (specificity 89.6%), outperforming LqSOFA and CHOP.
- qPS4 sensitivity for Phoenix septic shock: 85.5% (specificity 89.0%), higher than LqSOFA and CHOP.
- Analysis included 47,176 ED encounters with outcomes assessed within 24 hours.
Methodological Strengths
- Very large cohort enabling precise estimates of sensitivity/specificity.
- Direct, head-to-head comparison of three screening tools against Phoenix outcomes.
Limitations
- Retrospective secondary analysis with potential information bias from EHR data.
- Generalizability outside the study setting and to different resource environments is uncertain.
Future Directions: Prospective, multi-center validation and implementation studies assessing clinical impact on time-to-treatment and outcomes are warranted.
BACKGROUND AND OBJECTIVES: The Phoenix criteria for pediatric sepsis and septic shock have recently been proposed for worldwide application. The Phoenix sepsis criteria are based on organ dysfunction scoring. Although many screening tools exist, their performance in predicting Phoenix outcomes is not known. We hypothesized that the quick Pediatric Septic Shock Screening Score (qPS4) would demonstrate greater sensitivity compared with the Liverpool quick Sequential Organ Failure Assessment (LqSOFA) and a commonly used 2-stage screening tool created at Children's Hospital of Philadelphia (CHOP). METHODS: We performed a secondary analysis of the qPS4 validation set data from a retrospective cohort study of pediatric emergency department patients with suspected infection. The exposure was a positive screen prior to outcome occurring. We calculated the predictive characteristics of qPS4, LqSOFA, and CHOP for Phoenix sepsis and septic shock within 24 hours of arrival. RESULTS: We analyzed 47 176 encounters. Within 24 hours of arrival to the ED, 628 (1.3%) met criteria for sepsis and 228 (0.5%) met criteria for septic shock. The qPS4 predicted sepsis with 67.8% sensitivity and 89.6% specificity compared with LqSOFA (sensitivity 47.0%, specificity 95.7%) and the CHOP screen (sensitivity 49.7%, specificity 92.1%) (P < .05 for all compared to qPS4). The qPS4 predicted septic shock with 85.5% sensitivity and 89.0% specificity compared with LqSOFA (sensitivity 59.2%, specificity 95.2%) and the 2-stage CHOP screen (sensitivity 64.9%, specificity 91.5%) (P < .05 for all compared to qPS4). CONCLUSIONS: The qPS4 predicted Phoenix sepsis and septic shock with greater sensitivity and clinically similar specificity compared with widely used bedside tools.
2. Novel pulse pressure pattern monitoring in critical care of elderly sepsis patients.
Across four datasets including 12,525 elderly ICU sepsis patients, a sustained low pulse pressure phenotype (PP <45 mmHg at 72 hours, lasting >3 hours) was associated with markedly higher 28-day mortality (HR 2.36, 95% CI 2.12–2.63). External validations support integrating dynamic PP pattern monitoring to guide ongoing resuscitation.
Impact: Introduces a dynamic, easily monitored bedside phenotype that robustly stratifies risk in elderly sepsis across heterogeneous datasets.
Clinical Implications: Sustained low PP after ICU admission should trigger reassessment of preload/afterload balance, vasopressor titration, and cardiac function evaluation, informing individualized resuscitation.
Key Findings
- Identified a low pulse pressure phenotype (PP <45 mmHg at 72 hours, >3-hour duration) linked to higher 28-day mortality.
- Hazard ratio for mortality 2.36 (95% CI 2.12–2.63) in the inference dataset.
- Findings were consistent across multiple heterogeneous validation datasets.
Methodological Strengths
- Large, multi-source datasets with external validation enhance generalizability.
- Time-to-event modeling (PAMM) captures dynamic physiologic patterns.
Limitations
- Observational design cannot infer causality; residual confounding likely.
- PP may be influenced by arrhythmias, vasoactive drugs, and measurement variability.
Future Directions: Prospective studies to test PP-guided resuscitation protocols and integration into real-time decision support systems are needed.
OBJECTIVE: Our research aimed to explore the application of pulse pressure (PP) at the bedside of elderly intensive care unit (ICU) patients with sepsis through a large-scale retrospective cohort study. METHODS: We obtained data from four heterogeneous datasets, which included information on elderly sepsis patients (≥ 65 years). The data were divided into the inference and validation datasets. Thereby enhancing the generalizability of the study. The primary outcome was mortality at 28 days, and piecewise exponential additive mixed model (PAMM) were employed to estimate the strength of the associations over time. RESULTS: We included 12,525 elderly patients with sepsis in the initial inference dataset. Based on the PAMM's inference results, we identified a specific low PP phenotype from the time-dependent endpoint dataset. The phenotype indicates an imbalance between the patient's cardiac pumping ability and circulatory resistance, contributing to an increased 28-day mortality (hazard ratio, 2.36; 95% CI, 2.12-2.63). The consistency of these results was validated using data from various sources. CONCLUSION: Low PP phenotype (PP < 45 mmHg 72 h after intensive care unit admission and lasting for > 3h) may provide an early dynamic warning of the therapeutic effects of resuscitation interventions in long-hospitalized elderly patients with sepsis. IMPLICATIONS FOR CLINICAL PRACTICE: The results demonstrate acceptable consistency across heterogeneous datasets and hold promise for further development and integration into bedside monitoring systems for elderly sepsis patients.
3. SHRs, biomarkers for dysregulated stress response, predict prognosis in sepsis patients: a retrospective cohort study from MIMIC-IV database.
In 5,025 MIMIC-IV sepsis patients, all SHR metrics correlated with mortality, with SHRmax showing the strongest discrimination for both 28-day and 1-year outcomes. Each 1-unit increase in SHRmax raised mortality by 71.6% after adjustment, with stronger effects in non-diabetics.
Impact: Establishes a robust, standardized metabolic stress biomarker (SHRmax) for prognostication using widely available early glucose data.
Clinical Implications: Early calculation of SHRmax can enhance risk stratification and may inform glucose management strategies in septic patients, especially those without diabetes.
Key Findings
- Among SHR metrics, SHRmax had the highest predictive value for 28-day and 1-year mortality.
- Each 1-unit increase in SHRmax was associated with a 71.6% increase in mortality in multivariable analysis.
- Associations were stronger in non-diabetic patients; all P-values <0.001.
Methodological Strengths
- Large ICU database with comprehensive covariate adjustment and survival analyses.
- Comparison of multiple SHR definitions with sensitivity analyses by diabetes status.
Limitations
- Single-database retrospective study; external generalizability not directly tested.
- SHR is observational; interventional implications for glucose control remain unproven.
Future Directions: Prospective, multi-center validation and trials testing SHR-guided glucose and stress response modulation strategies.
BACKGROUND: The dysregulated stress response is a key pathological mechanism underlying sepsis and is strongly associated with poor clinical outcomes. Stress hyperglycemia, a common manifestation of this response, may provide valuable prognostic information in sepsis patients. The stress hyperglycemia ratio (SHR) offers a more accurate reflection of the stress response and may be instrumental in assessing sepsis prognosis. METHODS: This study aimed to investigate the relationship between SHRs and clinical outcomes in sepsis patients. Data were obtained from the Medical Information Mart for Intensive Care IV database. Demographic information, intensive care unit (ICU) parameters within the first 24 h, laboratory results, insulin administration, survival time, and outcomes were extracted for analysis. Four SHR metrics (SHRfirst, SHRmin, SHRmax, and SHRmean) were calculated based on blood glucose values during the first 24 h of ICU admission (first, minimum, maximum, and mean, respectively). The predictive performance of each SHR metric was compared using the area under the receiver operating characteristic (ROC) curve. Kaplan-Meier survival analysis was performed to assess survival rates across groups defined by ROC curve-generated cut-off values. Associations between SHR and 28-day as well as 1-year mortality were further examined using both univariate and multivariate Cox regression analyses. RESULTS: A total of 5,025 sepsis patients were included, of whom 656 died within 28 days of ICU admission. SHR was significantly higher in the non-survivor group. Among the SHR metrics, SHRmax demonstrated the highest predictive value for both 28-day and 1-year mortality. Higher SHR values were consistently associated with increased mortality (all P < 0.001). For SHRmax, each 1-unit increase was associated with a 77% increase in mortality in univariate analysis and a 71.6% increase in multivariate analysis. Sensitivity analyses indicated that the relationship between SHR and mortality was stronger in patients without diabetes. CONCLUSIONS: SHR serves as a robust marker of the dysregulated stress response in sepsis and holds significant prognostic value, particularly SHRmax, in predicting mortality. These findings underscore the potential clinical utility of SHR in guiding therapeutic strategies aimed at modulating the stress response and blood glucose levels in critically ill sepsis patients. Further research is warranted to explore SHR-targeted interventions in sepsis management.